Suppr超能文献

地塞米松和双氯芬酸在减轻下颌第三磨牙手术后并发症方面的超前镇痛效果:一项系统评价

Preemptive Analgesic Efficacy of Dexamethasone and Diclofenac in Mitigating Post-surgical Complications After Mandibular Third-Molar Surgery: A Systematic Review.

作者信息

Satyanarayana Killampalli Dr Yashwanth V, Yuwanati Monal, Krishnan Murugesan, Kumar Santhosh P, George Melvin, Lakshmanan Saravanan

机构信息

Oral and Maxillofacial Surgery, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

Oral Pathology, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, IND.

出版信息

Cureus. 2023 Jul 30;15(7):e42709. doi: 10.7759/cureus.42709. eCollection 2023 Jul.

Abstract

Mandibular third-molar extraction is a frequently executed minor oral surgical procedure, with a subsequent recovery period lasting several days. Typically, preemptive administration of non-steroid anti-inflammatory drugs (NSAIDs) and steroids has been employed, resulting in a notable decrease in postoperative complications like pain, facial swelling, trismus, and alveolar osteitis. This systematic review's primary goal was to investigate the efficacy of preemptive analgesia with dexamethasone and diclofenac in minimizing the post-surgical complications following the surgical extraction of the mandibular third molars. The systematic search was carried out to identify relevant literature in digital databases including PubMed®, Cochrane Library, Web of Science, and Scopus, from January 1990 to January 2022. The search used specific keywords. The randomized clinical trials assessing the efficacy of dexamethasone and diclofenac or dexamethasone alone compared to diclofenac or placebo as preemptive analgesics were considered inclusion criteria for this systematic review. Case reports, literature reviews, letters to the editor, and non-English publications were not included. Two authors screened the titles and abstracts, and articles fulfilling the study criteria were included. After reading the full text and data collection, analysis was performed. The included article's bias was evaluated by the Risk of Bias 2 (RoB 2) tool. A digital database search yielded a total of 207 articles. After excluding duplicates and articles written in languages other than English, 90 were removed. Based on the title and abstract, out of 177, 95 studies were excluded. After full-text reading of 22 articles, 17 were eliminated because they did not meet the inclusion and exclusion criteria. The remaining five studies were found eligible and included in the systematic review. Four studies were of low risk, while one study had some concerns. Two studies evaluated the combination of dexamethasone with diclofenac, while three evaluated dexamethasone alone. Total samples included samples of 436 third-molar surgeries in 420 patients. There was a substantial decrease in the mean pain score and swelling measurement when diclofenac alone was compared with coadministration of diclofenac and dexamethasone. Preemptive administration of dexamethasone and diclofenac has been shown to effectively reduce pain and facial swelling, with the exception of trismus, in third-molar surgeries when compared to diclofenac alone. As a result, it is recommended to administer these drugs prior to the commencement of third-molar extraction. However, further research is mandatory, specifically good quality randomized controlled trials involving large cohorts, in order to assess any significant variations and validate these findings.

摘要

下颌第三磨牙拔除术是一种常见的小型口腔外科手术,术后恢复期通常持续数天。通常会采用预防性给予非甾体抗炎药(NSAIDs)和类固醇,这使得疼痛、面部肿胀、牙关紧闭和干槽症等术后并发症显著减少。本系统评价的主要目的是研究地塞米松和双氯芬酸预防性镇痛在减少下颌第三磨牙拔除术后并发症方面的疗效。我们进行了系统检索,以确定1990年1月至2022年1月期间包括PubMed®、Cochrane图书馆、科学网和Scopus在内的数字数据库中的相关文献。检索使用了特定关键词。评估地塞米松和双氯芬酸联合使用或单独使用地塞米松与单独使用双氯芬酸或安慰剂作为预防性镇痛药疗效的随机临床试验被视为本系统评价的纳入标准。病例报告、文献综述、给编辑的信以及非英文出版物均未纳入。两名作者筛选了标题和摘要,纳入了符合研究标准的文章。在阅读全文并进行数据收集后,进行了分析。使用偏倚风险2(RoB 2)工具评估纳入文章的偏倚。数字数据库检索共获得207篇文章。排除重复文章和非英文撰写的文章后,排除了90篇。根据标题和摘要,在177篇文章中,排除了95项研究。在对22篇文章进行全文阅读后,排除了17篇,因为它们不符合纳入和排除标准。其余5项研究被认为符合条件并纳入系统评价。4项研究风险较低,1项研究存在一些问题。2项研究评估了地塞米松与双氯芬酸的联合使用,3项研究评估了单独使用地塞米松。总样本包括420例患者的436例第三磨牙手术样本。与单独使用双氯芬酸相比,双氯芬酸与地塞米松联合使用时,平均疼痛评分和肿胀测量值显著降低。与单独使用双氯芬酸相比,在地塞米松和双氯芬酸预防性给药的第三磨牙手术中,除牙关紧闭外,已证明可有效减轻疼痛和面部肿胀。因此,建议在开始下颌第三磨牙拔除术前使用这些药物。然而,必须进行进一步的研究,特别是涉及大型队列的高质量随机对照试验,以评估任何显著差异并验证这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ed2b/10468144/fd00a19f3f01/cureus-0015-00000042709-i01.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验